Our research focuses on identifying therapeutic strategies for the treatment of colorectal cancer. We are focused on targeting the unique vulnerabilities of cancer cells when they are in the drug tolerant state. Genetics, proteomics, transcriptomics, bioinformatics, Genome-wide CRISPR-Cas9 screening, biochemistry and molecular analyses of human cancer cells, mouse models and primary samples (including organoid culures) are used for our studies.
Leave a Reply